# Nation-wide Health Resource Consumption and Costs Associated With Mepolizumab

> **NCT04550780** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 7938 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Mepolizumab

## Key facts

- **NCT ID:** NCT04550780
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-03
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 7938 (ACTUAL)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04550780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04550780, "Nation-wide Health Resource Consumption and Costs Associated With Mepolizumab". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04550780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*